These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22457216)

  • 1. Targeting TNF receptors in rheumatoid arthritis.
    Blüml S; Scheinecker C; Smolen JS; Redlich K
    Int Immunol; 2012 May; 24(5):275-81. PubMed ID: 22457216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome.
    Jit M; Henderson B; Stevens M; Seymour RM
    Rheumatology (Oxford); 2005 Mar; 44(3):323-31. PubMed ID: 15585509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the next generation of anti-TNF drugs.
    Sfikakis PP; Tsokos GC
    Clin Immunol; 2011 Dec; 141(3):231-5. PubMed ID: 22004846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein].
    Fujikawa K; Kawakami A; Eguchi K
    Nihon Rinsho; 2007 Jul; 65(7):1211-7. PubMed ID: 17642234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW
    South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW
    Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF inhibitors in the treatment of arthritis.
    Lorenz HM
    Curr Opin Investig Drugs; 2000 Oct; 1(2):188-93. PubMed ID: 11249572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
    Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
    Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
    Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].
    Larsson P; Bratt J; Harju A; van Vollenhoven R; Klareskog L
    Lakartidningen; 2001 Feb; 98(8):828-31. PubMed ID: 11265568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-mediated inflammatory disease.
    Bradley JR
    J Pathol; 2008 Jan; 214(2):149-60. PubMed ID: 18161752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation.
    Vielhauer V; Mayadas TN
    Semin Nephrol; 2007 May; 27(3):286-308. PubMed ID: 17533007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland.
    Cairns AP; Taggart AJ
    Ulster Med J; 2002 Nov; 71(2):101-5. PubMed ID: 12513005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
    Ehlers S
    J Rheumatol Suppl; 2005 Mar; 74():35-9. PubMed ID: 15742463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
    Bondeson J; Maini RN
    Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases.
    Bystrom J; Clanchy FI; Taher TE; Mangat P; Jawad AS; Williams RO; Mageed RA
    Cytokine; 2018 Jan; 101():4-13. PubMed ID: 27639923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1.
    Van Hauwermeiren F; Vandenbroucke RE; Libert C
    Cytokine Growth Factor Rev; 2011; 22(5-6):311-9. PubMed ID: 21962830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF and TNFR biology in health and disease.
    McDermott MF
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):619-35. PubMed ID: 11502070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.